Phathom Pharmaceuticals (PHAT) Revenue: 2022-2025
Historic Revenue for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to $49.5 million.
- Phathom Pharmaceuticals' Revenue rose 202.74% to $49.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.2 million, marking a year-over-year increase of 460.30%. This contributed to the annual value of $55.3 million for FY2024, which is 8001.47% up from last year.
- As of Q3 2025, Phathom Pharmaceuticals' Revenue stood at $49.5 million, which was up 25.32% from $39.5 million recorded in Q2 2025.
- In the past 5 years, Phathom Pharmaceuticals' Revenue ranged from a high of $49.5 million in Q3 2025 and a low of -$10.1 million during Q3 2023.
- Its 3-year average for Revenue is $13.1 million, with a median of $7.3 million in 2024.
- As far as peak fluctuations go, Phathom Pharmaceuticals' Revenue crashed by 234.07% in 2023, and later skyrocketed by 4,249.56% in 2024.
- Phathom Pharmaceuticals' Revenue (Quarterly) stood at -$9.6 million in 2022, then spiked by 107.10% to $682,000 in 2023, then skyrocketed by 4,249.56% to $29.7 million in 2024, then spiked by 202.74% to $49.5 million in 2025.
- Its last three reported values are $49.5 million in Q3 2025, $39.5 million for Q2 2025, and $28.5 million during Q1 2025.